Millennium had faced some skepticism when it said it would file for FDA approval a year ahead of its original schedule, before a larger clinical study could be completed.
Even within DoD itself, Foreign Military Sales programs are subject to approval by up to five technology-transfer committees, each of which operates on its own schedule.